After residency, Leslie Ballas, MD spent time on the faculty at MD Anderson Cancer Center treating hematologic malignancies (leukemia, lymphoma and multiple myeloma). Dr. Ballas has considerable experience treating this patient population. Because many lymphomas are highly curable, management of long term side effects from treatment is essential. She has used many different treatment techniques and modalities to minimize radiation dose to normal structures, thereby minimizing late effects from treatment. Dr. Ballas also has a great deal of experience working with cutaneous lymphomas and the management of this category of lymphomas.
Dr. Leslie Ballas also specializes in cancers of the genitourinary tract, including malignancies of the prostate, urinary bladder, testicle, and kidney. Her research has focused on improving quality of life for men with prostate cancer. She is involved in the development of cancer treatment clinical trials for patients with genitourinary cancers and has brought multiple genitourinary cooperative group studies to USC. Dr. Ballas’ interests include advanced technology integration into cancer therapeutics, including image-guide radiation therapy (IGRT), stereotactic body radiotherapy (SBRT), and intensity modulated radiotherapy (IMRT).
University of Michigan Medical School
General Surgery, New York Hospital Weill-Cornell University
Radiation Oncology, Columbia Prebyterian Hosptial
Research, Memorial Sloan Kettering
Radiation Oncology - American Board of Radiology
American Society for Therapeutic Radiology and Oncology (ASTRO)
American College of Radiology (ACR)
Internaltional Lymphoma Radiation Oncology Group (ILROG)
Los Angeles Radiology Society (LARS)
Postdoctoral Fellowship Award, NIH Ruth L. Kirschstein National Research Service
ASTRO Health Services/Outcomes Research In Radiation Oncology Symposium, Travel Grant
Research Award of Excellence, University of Michigan Medical School
Satkunasivam R, Kim AE, Desai M, Nguyen MM, Quinn DI, Ballas L, Lewinger JP, Stern MC, Hamilton AS, Aron M, Gill IS. Radical Prostatectomy or External Beam Radiation Therapy vs No Local Therapy for Survival Benefit in Metastatic Prostate Cancer: A SEER-Medicare Analysis. J Urol. 2015 Aug; 194(2):378-85.
Ballas LK, Hu BR, Quinn DI. Chromoplexy and hypoxic microenvironment drives prostate cancer. Lancet Oncol. 2014 Dec; 15(13):1419-21.
Dabaja B, Wang Z, Stovall M, Baker JS, Smith SA, Khan M, Ballas L, Salehpour MR. Involved field radiation for Hodgkin's lymphoma: the actual dose to breasts in close proximity. Med Dosim. 2012; 37(4):374-82.
Shihadeh F, Reed V, Faderl S, Medeiros LJ, Mazloom A, Hadziahmetovic M, Kantarjian H, Allen P, Ballas L, Pierce S, Dabaja B. Cytogenetic profile of patients with acute myeloid leukemia and central nervous system disease. Cancer. 2012 Jan 1; 118(1):112-7.
Lymphomas and GU Malignancies